Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep
Part of paid clinical trials in Glendale, Arizona.
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Study ID
- NCT03575104
- Phase
- PHASE3
- Status
- Completed
Conditions
- Insomnia Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Daridorexant — DRUGDaridorexant will be administered as tablets, orally, once daily in the evening.
- Placebo — OTHERMatching placebo will be administered as tablets, orally, once daily in the evening.
Study Details
The main purpose of this study is to assess efficacy and safety of ACT-541468 (daridorexant) in adult and elderly subjects with insomnia disorder. Efficacy will be evaluated on objective and subjective sleep parameters.
Key Dates
- Start date
- May 29, 2018
- Status verified
- Mar 2022
- Primary completion
- Apr 9, 2020
- Completion
- May 14, 2020
Study Design
- Enrollment
- 924 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Daridorexant 10 mg
- Experimental: Daridorexant 25 mg
- Placebo Comparator: Placebo
Primary Outcome Measure
Change From Baseline to Month 1 in Wake After Sleep Onset (WASO) (Sleep Maintenance) [ Time Frame: From baseline to Month 1 (i.e. for up to 1 month) ]
Locations (37)
Find similar trials in Glendale, AZ
By research site
Related Studies
- Brief Behavioral Treatment for Insomnia in Veterans With Posttraumatic Stress DisorderRecruiting · VA Office of Research and Development · San Francisco, California
- Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric InsomniaPHASE3 · Recruiting · Vanda Pharmaceuticals · Dothan, Alabama
- Optimizing an Integrated Mind and Body Treatment for Insomnia: The SLEEPS Study 2Recruiting · University of California, San Francisco · San Francisco, California
- A SMART Approach to Evaluating the Benefits of Common Prescription and OTC Medications for InsomniaPHASE4 · Recruiting · University of Pennsylvania · Philadelphia, Pennsylvania